TY - JOUR
T1 - Diagnostic Tools for Calculation of Glaucoma Risk
AU - Mansberger, Steve L.
AU - Medeiros, Felipe A.
AU - Gordon, Mae
N1 - Funding Information:
The supplement in which this article is published was funded by Pfizer. The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article. This article was supported in part by grants from NEI 3 K23 EY0155501-01 (S.L.M.), NEI EY09341, EY09307 (M.G.), Merck Research Laboratories (M.G.), and Research to Prevent Blindness (M.G.).
PY - 2008/11
Y1 - 2008/11
N2 - Risk calculators may simplify the management of ocular hypertension and glaucoma patients and provide evidence-based treatment. Risk calculators are not new to medicine. Medical providers use risk calculators to guide decision-making for the risk of a chromosomal abnormality in neonates, osteoporosis in postmenopausal women, and cardiovascular disease in adults. This article describes the current knowledge of risk calculators in ophthalmology. Clinicians should recognize that the current risk calculators do not include critical information guiding treatment such as life expectancy and patient's willingness to commit to years of eye drops. Overall, eye-care providers should consider the results of a risk calculator as supplemental information when treating an ocular hypertension or glaucoma patient.
AB - Risk calculators may simplify the management of ocular hypertension and glaucoma patients and provide evidence-based treatment. Risk calculators are not new to medicine. Medical providers use risk calculators to guide decision-making for the risk of a chromosomal abnormality in neonates, osteoporosis in postmenopausal women, and cardiovascular disease in adults. This article describes the current knowledge of risk calculators in ophthalmology. Clinicians should recognize that the current risk calculators do not include critical information guiding treatment such as life expectancy and patient's willingness to commit to years of eye drops. Overall, eye-care providers should consider the results of a risk calculator as supplemental information when treating an ocular hypertension or glaucoma patient.
KW - Early Manifest Glaucoma trial
KW - European Glaucoma Prevention study
KW - Ocular Hypertension Treatment Study
KW - glaucoma
KW - ocular hypertension
KW - risk assessment
KW - risk calculator
UR - http://www.scopus.com/inward/record.url?scp=56449085490&partnerID=8YFLogxK
U2 - 10.1016/j.survophthal.2008.08.005
DO - 10.1016/j.survophthal.2008.08.005
M3 - Article
C2 - 19038619
AN - SCOPUS:56449085490
SN - 0039-6257
VL - 53
SP - S11-S16
JO - Survey of ophthalmology
JF - Survey of ophthalmology
IS - 6 SUPPL.
ER -